Roman Herout

Dr. Roman Herout


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Journal of Endourology
Verified
Journal Article
Closed access
BCBen H. Chew
Ben H. Chew
NSNabil Shalabi
Nabil Shalabi
RHRoman Herout
Roman Herout
ARAlina Reicherz
Alina Reicherz
VWVictor Wong
Victor Wong
NBNaeem Bhojani
Naeem Bhojani
Introduction: Intrarenal pressure is emerging as an important monitoring parameter during flexible ureteroscopy (fURS). We measure how intraoperative conditions affect intrarenal pressure using a novel pressure sensing ureteroscope. Methods: The LithoVue Elite (LVE) single-use digital flexible ureteroscope (Boston Scientific) is the first commercial ureteroscope that senses pressure at its tip. LVE was used in a porcine model to measure intrarenal pressure with and without a ureteral access sheath (UAS) with various sizes and placement locations, irrigation methods, and working channel accessories. LVE pressure accuracy was measured in a bench model. This abstract shows the least-square means from multiway analysis of variances used for analysis. Results: Intrarenal pressures were the highest without a UAS (64 mm Hg), followed by the 11/13 UAS (51 mm Hg) and the 12/14 and 13/15, which were not statistically different (39–40 mm Hg). The pressures were highest with UASs placed at the ureteropelvic junction (61 mm Hg), and lowest if placed in the renal pelvis (24 mm Hg). Irrigation methods showed the highest pressures with syringe (57 mm Hg), while irrigation bags (pressurized at 150–300 mm Hg) produced 43 to 46 mm Hg and 25 mm Hg when applied with 80 cm of gravity. Placing a 200 μm laser fiber reduced pressures from 44 to 41 mm Hg. Finally, the bench model showed that LVE was 96% accurate up to 300 mm Hg. Conclusion: Intrarenal pressure significantly varied based on UAS sizes, placement, and irrigation methods. Accordingly, fURS with LVE is poised to be an invaluable tool for clinical decision-making and future studies of intrarenal pressure.

28 August 2021 in World Journal of Urology
Verified
Journal Article
Open access
PDF file
RHRoman Herout
Roman Herout
MBMartin Baunacke
Martin Baunacke
CGChrister Groeben
Christer Groeben
CACem Aksoy
Cem Aksoy
BVBjörn Volkmer
Björn Volkmer
JHJohannes Huber
Johannes Huber
Purpose: To describe the change in upper urinary tract stone management in Germany over a 14-year period. Methods: Using remote data processing we analyzed the nationwide German billing data from 2006 to 2019. To analyze the clinics’ case numbers and regional trends, we used the reimbursement.INFO tool based on standardized quality reports of all German hospitals. To also cover shock wave lithotripsy (SWL) as an outpatient procedure, we analyzed the research database of the Institute for Applied Health Research with a representative anonymous sample of 4 million insured persons. Results: The number of inpatient interventional therapies for upper tract urolithiasis in Germany increased from 70,099 cases in 2006 to 94,815 cases in 2019 (trend p < 0.0001). In-hospital SWL declined from 41,687 cases in 2006 to 10,724 cases in 2019 (decline of 74%; trend p < 0.0001). The percentage of SWL as an outpatient procedure increased between 2013 and 2018 from 36 to 46% of all performed SWL, while total SWL case numbers declined. Contrarily, the number of ureteroscopies increased from 32,203 cases in 2006 to 78,125 cases in 2019 (increase of 143%; trend p < 0.0001). The number of percutaneous nephrolithotomy also increased from 1673 cases in 2006 to 8937 in 2019 (increase of 434%; trend p < 0.0001). Conclusion: We observed an increase in interventional therapy for upper tract urolithiasis in Germany with a dramatic shift from SWL to endoscopic/percutaneous treatment. These changes may be attributed to enormous technological advances of the endoscopic armamentarium and to reimbursement issues.

29 November 2022 in World Journal of Urology
Verified
Journal Article
Open access
PDF file
RHRoman Herout
Roman Herout
MBMartin Baunacke
Martin Baunacke
LFLuka Flegar
Luka Flegar
ABAngelika Borkowetz
Angelika Borkowetz
ARAlina Reicherz
Alina Reicherz
JHJohannes Huber
Johannes Huber
Purpose: To report contemporary epidemiological data and treatment trends for upper tract urothelial carcinoma (UTUC) in Germany over a 14-year period. Methods: We analyzed data from the nationwide German hospital billing database and the German cancer registry from 2006 to 2018/2019. The significance of changes over time was evaluated via regression analysis. Survival outcomes were calculated using the Kaplan–Meier method. Results: There was a non-significant increase in the age-standardized incidence rate from 2.5/100,000 in 2006 to 2.9/100.000 in 2018. 13% of patients presented with lymph node metastasis and 7.6% of patients presented with distant metastasis at primary diagnosis. The 5-year overall survival was estimated at 45% and the 10-year overall survival at 32%. Endoscopic biopsies of the renal pelvis and ureter as well as ureteroscopies with excision/destruction of UTUC all increased significantly over the study period. The number of radical nephroureterectomies (RNU) for UTUC steadily increased from 1643 cases in 2006 to 2238 cases in 2019 (p < 0.005) with a shift from open surgery towards minimally invasive surgery. Complex reconstructive procedures like ileal ureter replacement or autotransplantation are rarely performed for urothelial carcinoma of the ureter. Conclusion: Diagnostic and therapeutic procedures for UTUC have increased and minimally invasive nephroureterectomy is the predominant approach concerning radical surgery in 2019.

1 January 2018 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
RHRoman Herout
Roman Herout
JGJohannes Graff
Johannes Graff
ABAngelika Borkowetz
Angelika Borkowetz
SZStefan Zastrow
Stefan Zastrow
SLSteffen Leike
Steffen Leike
MFMichael Froehner
Michael Froehner

24 March 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
RHRoman Herout
Roman Herout
SKSara Khoddami
Sara Khoddami
IMIgor Moskalev
Igor Moskalev
ARAlina Reicherz
Alina Reicherz
BCBen H. Chew
Ben H. Chew
Dirk LangeDirk Lange
Dirk Lange
Proteus mirabilis (PM) is a Gram-negative, rod-shaped bacterium that causes catheter-associated urinary tract infections (CAUTIs). The specific roles of bacterial surface components (BSCs) in PM pathogenicity and CAUTIs remain unknown. To address this knowledge gap, we utilized relevant in vitro adhesion/invasion models and a well-established murine model of CAUTI to assess the ability of wildtype (WT) and seven mutant strains (MSs) of PM with deficiencies in various genes encoding BSCs to undergo the infectious process (including adhesion to catheters) in both model systems. Overall, MSs adhesion to catheters and the different cell types tested was significantly reduced compared to WT, while no invasion of cells was evident at 24 h. In vivo, WT showed a greater number of planktonic (urine) bacteria, bacteria adherent to catheters, and bacteria adherent to/invading bladder tissue when compared to the MSs. Bacterial counts in urine for PMI3191 and waaE mutants were lower than that for WT and other MSs. The complementation of mutated BSC genes resulting in the biggest defects restored the invasion phenotype both in vitro and in vivo. BSCs play a critical role at various steps in the pathogenicity of PM including adhesion to indwelling medical devices and adhesion/invasion of urinary tissue in vivo.

9 May 2023 in Journal of Endourology
Verified
Journal Article
Closed access
RHRoman Herout
Roman Herout
AHAbdulghafour H Halawani
Abdulghafour H Halawani
VWVictor Wong
Victor Wong
KKKyo Chul Koo
Kyo Chul Koo
TZTianshuang Zhong
Tianshuang Zhong
BCBen H. Chew
Ben H. Chew
Objective: The purpose of this study is to evaluate the current availability of technology for urolithiasis treatment and ureteroscopy. Perioperative practice patterns, availability of ureteroscopic technologies, pre- and post-stenting practices, and methods to alleviate stent-related symptoms were assessed via a survey of members of the Endourological Society. Methods We distributed a 43-question survey online via the Qualtrics platform to members of the Endourological Society. The survey consisted of questions pertaining to the following topics: general (6), equipment (17), preoperative ureteroscopy (URS; 9), intraoperative URS (2), and postoperative URS (9). Results A total of 191 urologists responded to the survey. 51% of urologists were fellowship trained and dedicated an average of 58% of their practice to stone management. In terms of procedures, most urologists performed ureteroscopy most commonly (68%), followed by percutaneous nephrolithotomy (23%) and shockwave lithotripsy (11%). 90% of respondent urologists purchased a new ureteroscope within the last five years (16% single-use scopes, 53% reusable, and 31% purchased both). 57% of the respondents stated that they would be interested in a ureteroscope that can sense intrarenal pressure, with an additional 30% stating they would be interested depending on the cost. 80% of responders purchased a new laser within the last five years, and 59% changed their lasering technique due to the new laser. 70% are performing primary ureteroscopy for obstructing stones, and 30% prefer pre-stenting patients for subsequent URS (on average after 21 days). 59% of responders insert a ureteral stent after URS, which is removed, on average, after eight days in uncomplicated cases and 21 days after complicated URS. Most urologists give analgesics, alpha-blockers, and anticholinergics for stent-related symptoms and less than 10% prescribe opioids. Conclusion Our survey revealed urologists’ eagerness for the early adoption of novel technologies and adherence to conservative practice patterns focused on patient safety.